WS12.2 – Optimizing Direct-to-Patient Distribution: Addressing Barriers for Sustainable Trial Integration (A)

This advanced level session explores actionable strategies to enhance the feasibility of Direct-to-Patient (DTP) distribution in clinical trials. Drawing on Tufts & GCSG Impact Summary insights, we’ll examine key challenges—technical support gaps, delivery logistics, and scheduling inefficiencies—and discussion solutions to improve site and patient experiences. Attendees will leave with a roadmap for maintaining DTP as a viable and patient-centric trial model.